The diminished cellular levels of RasGRF2 in AnxA6 expressing cells and the associated decrease in the activation of Ras and ERK1/2 as well as reduced tumor growth are consistent with the inhibition of the growth of AnxA6 expressing tumor cells. Here, ANXA6 is linked to neoplasm.